For NF2-related schwannomatosis patients, timing of care and community support are key to preserving quality of life. Discover the nuances of NF2-SWN care.
Laura Klesse, M.D., Ph.D. /
Justin Jordan, M.D., M.P.H. /
J. Walter Kutz, M.D.
A remarkable story of science and survival, fueled by a frontier mentality that defines UT Southwestern Medical Center, leads to the development of a new drug that gives fresh hope to patients with low-grade gliomas.
Two studies underway at UT Southwestern are building upon existing nanoparticle technology to deliver brain cancer medications directly to the brain. UT Southwestern discusses how the ReSPECT clinical trials may give hope to patients living with glioblastoma and leptomeningeal disease.
Successful outcomes in Gamma Knife radiosurgery require a team approach – and a lot of quality checks. UT Southwestern discusses the process in this week's MedBlog.
